Phase I/II, open-label, multiple ascending dose trial of AGEN2034, an anti–PD-1 monoclonal antibody, in advanced solid malignancies: Results of dose escalation in advanced cancer and expansion cohorts in subjects with relapsed/refractory cervical cancer
Saved in:
| Published in | Annals of oncology Vol. 29; pp. viii412 - viii413 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
Elsevier Ltd
01.10.2018
|
| Online Access | Get full text |
| ISSN | 0923-7534 1569-8041 1569-8041 |
| DOI | 10.1093/annonc/mdy288.031 |
Cover
| Author | Drescher, C. Subbiah, V. Buell, J.S. Youssoufian, H. Shebanova, O. Liu, J.F. Wilky, B.A. Wang, E.W. Gonzalez, A.M. Yuan, G. O’Malley, D.M. Wang, J.S.-Z. Dupont, C.D. Stein, R.B. Coulter, S. Moore, K.N. Savitsky, D. Dow, E. Ortuzar, W. |
|---|---|
| Author_xml | – sequence: 1 givenname: C. surname: Drescher fullname: Drescher, C. organization: Gynecologic Oncology, Pacific Gynecology Specialists Seattle, Seattle, WA, USA – sequence: 2 givenname: K.N. surname: Moore fullname: Moore, K.N. organization: Gynecologic Oncology, Stephenson Cancer Center at the University of Oklahoma Health Sciences Center/Sarah Cannon Research Institute, Oklahoma City, OK, USA – sequence: 3 givenname: J.F. surname: Liu fullname: Liu, J.F. organization: Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA – sequence: 4 givenname: D.M. surname: O’Malley fullname: O’Malley, D.M. organization: Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, OH, USA – sequence: 5 givenname: E.W. surname: Wang fullname: Wang, E.W. organization: Medical Oncology & Therapeutics Research, Penn State College of Medicine, Hershey, PA, USA – sequence: 6 givenname: J.S.-Z. surname: Wang fullname: Wang, J.S.-Z. organization: Medical Oncology, Sarah Cannon, Sarasota, FL, USA – sequence: 7 givenname: V. surname: Subbiah fullname: Subbiah, V. organization: Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA – sequence: 8 givenname: B.A. surname: Wilky fullname: Wilky, B.A. organization: Department of Medicine, Division of Hematology/Oncology, Sylvester Comprehensive Cancer Center, Miami, FL, USA – sequence: 9 givenname: G. surname: Yuan fullname: Yuan, G. organization: Statistics, Agenus Bio, Inc., Lexington, MA, USA – sequence: 10 givenname: C.D. surname: Dupont fullname: Dupont, C.D. organization: Tcell Biology, Agenus Bio, Inc., Lexington, MA, USA – sequence: 11 givenname: A.M. surname: Gonzalez fullname: Gonzalez, A.M. organization: Translational Medicine, Agenus Bio, Inc., Lexington, MA, USA – sequence: 12 givenname: D. surname: Savitsky fullname: Savitsky, D. organization: Tcell Biology, Agenus Bio, Inc., Lexington, MA, USA – sequence: 13 givenname: S. surname: Coulter fullname: Coulter, S. organization: Clinical Operations, Agenus Bio, Inc., Lexington, MA, USA – sequence: 14 givenname: O. surname: Shebanova fullname: Shebanova, O. organization: Program and Portfolio Management, Agenus Bio, Inc., Lexington, MA, USA – sequence: 15 givenname: E. surname: Dow fullname: Dow, E. organization: Development Management, Agenus Bio, Inc., Lexington, MA, USA – sequence: 16 givenname: W. surname: Ortuzar fullname: Ortuzar, W. organization: Corporate Communications, Agenus Bio, Inc., Lexington, MA, USA – sequence: 17 givenname: J.S. surname: Buell fullname: Buell, J.S. organization: Communications and External Affairs, Agenus Bio, Inc., Lexington, MA, USA – sequence: 18 givenname: R.B. surname: Stein fullname: Stein, R.B. organization: Research Management, Agenus Bio, Inc., Lexington, MA, USA – sequence: 19 givenname: H. surname: Youssoufian fullname: Youssoufian, H. organization: Clinical Operations, Agenus Bio, Inc., Lexington, MA, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32137035$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkU1uFDEQhS0URCaBA7BBPsB0xj89_QOrKCRhpAgiBOuW267JOHLbLbtnwuy4AzfMRaA6HZBgESFZslV-3yu73hE58MEDIa85O-GslgvlsaAXndmLqjphkj8jM74s6qxiOT8gM1YLmZVLmR-So5RuGWNFLeoX5FAKLksmlzPy83qjEtDVYrWa09CDz5xqwc1pt3WD7R1QlTR4Y_0NNQGVQ7TK0bCmp5fnHwWT-Zwqj2uw999_XL_POO2CD9oFj7Kx3Aazn1OLGrNTXoOhKThraKecvfFYsZDe0s-QsGEajR_aQNLKqcEG_xeqxy2ir6HwrVc-jQIdNiEii8K0bW9B4_nODhsawak-gVlEWEelhxD3FPGdRe9Hq5fk-Vq5BK8e92Py9eL8y9mH7OrT5ers9CrToqx4Vre8YNy0BeSlKPNctHxZLoXggpk1SKhqVoiqqMrWmLYFUeJNvQajdaGkgVweEzH5bn2v9nfKuaaPtlNx33DWjGk2U5rNlGaDaSL0ZoL6bduB-UP8jg8F5STQMaSEv2y0HR6mNkRl3ZPW_B_yf57zbmIAB7WzEJuE4Y252IhDb0ywT9C_AO803go |
| CitedBy_id | crossref_primary_10_3390_jcm10194523 crossref_primary_10_3389_fonc_2022_904790 crossref_primary_10_1016_j_critrevonc_2023_103925 crossref_primary_10_2217_fon_2021_0529 crossref_primary_10_1016_j_ygyno_2021_08_018 crossref_primary_10_1007_s12032_022_01646_7 |
| ContentType | Journal Article |
| Copyright | 2018 THE AUTHORS |
| Copyright_xml | – notice: 2018 THE AUTHORS |
| DBID | 6I. AAFTH AAYXX CITATION NPM ADTOC UNPAY |
| DOI | 10.1093/annonc/mdy288.031 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed Unpaywall for CDI: Periodical Content Unpaywall |
| DatabaseTitle | CrossRef PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1569-8041 |
| EndPage | viii413 |
| ExternalDocumentID | 10.1093/annonc/mdy288.031 32137035 10_1093_annonc_mdy288_031 S0923753419496154 |
| Genre | Journal Article |
| GroupedDBID | --- -E4 .2P .86 .I3 .XZ .ZR 08P 0R~ 0U7 1TH 23M 2WC 4.4 482 48X 53G 5GY 5VS 5WA 6.Y 6I. 6J9 70D AABJS AABMN AAEDW AAESY AAFTH AAIAV AAIYJ AAJKP AAJQQ AAKAS AAKUH AAMVS AAOGV AAPNW AAUQX AAXUO ABEUO ABIXL ABJNI ABKDP ABLJU ABNKS ABOCM ABQLI ABQTQ ABSAR ABSMQ ABVKL ABZBJ ACGFO ACGFS ACIMA ACMRT ACPQN ACPRK ACUFI ACUTO ADBBV ADEIU ADEYI ADHKW ADHZD ADJQC ADOCK ADORX ADQLU ADRIX ADRTK ADYVW ADZCM ADZXQ AEGPL AEGXH AEJOX AEKPW AEKSI AEMDU AENEX AENZO AEPUE AEWNT AFIYH AFOFC AFXEN AGINJ AGKEF AGKRT AGSYK AHMBA AHXPO AIAGR AIJHB AIKOY AITUG ALMA_UNASSIGNED_HOLDINGS ALUQC AMRAJ APIBT APWMN AQKUS ASMCH ASPBG ATTQO AVWKF AWCFO AXUDD AZFZN AZQFJ BAWUL BAYMD BEYMZ BGNMA BGYMP BHONS BTRTY BVRKM BZKNY C1A CAG CASEJ CDBKE CKLRP COF CS3 CZ4 DAKXR DIK DILTD DL5 DPORF DPPUQ D~K E3Z EBS EE~ EJD EX3 F9B FDB FEDTE GJXCC GX1 H5~ HAR HVGLF HW0 HZ~ I09 IH2 IHE IOX J21 KAQDR KC5 KDC KOM KOP KQ8 KSI KSN LAK M-Z M41 M49 M4Y MBLQV MHKGH N9A NCXOZ NGC NOYVH NTWIH NU- NU0 NVLIB O9- OAWHX ODMLO OJQWA OK1 OVD P2P P6G PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RNI ROL ROX ROZ RPX RW1 RXO RZC RZE RZF RZO SDH TCURE TEORI TJX TMA TR2 U2A W8F WOQ WOW X7H YAYTL YFH YKOAZ ZKX ZXP ~91 AAGQS AALRI AAYWO AAYXX ABNGD ACUKT ACVFH ADCNI ADVLN AEHUL AEUPX AFJKZ AFPUW AFSHK AGQPQ AIGII AKBMS AKRWK AKYEP APXCP CITATION EFKBS H13 AFETI NPM ADTOC UNPAY |
| ID | FETCH-LOGICAL-c2781-9b1601db6e4727442b157522120dfe3e890628687bddbbe272129fedcc6a3de43 |
| IEDL.DBID | UNPAY |
| ISSN | 0923-7534 1569-8041 |
| IngestDate | Wed Oct 01 15:45:41 EDT 2025 Wed Feb 19 02:30:46 EST 2025 Thu Apr 24 22:54:35 EDT 2025 Thu Oct 16 04:30:41 EDT 2025 Fri Feb 23 02:48:13 EST 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| License | http://www.elsevier.com/open-access/userlicense/1.0 cc-by-nc-nd |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c2781-9b1601db6e4727442b157522120dfe3e890628687bddbbe272129fedcc6a3de43 |
| OpenAccessLink | https://proxy.k.utb.cz/login?url=https://academic.oup.com/annonc/article-pdf/29/suppl_8/mdy288.031/26140708/mdy288.031.pdf |
| PMID | 32137035 |
| ParticipantIDs | unpaywall_primary_10_1093_annonc_mdy288_031 pubmed_primary_32137035 crossref_citationtrail_10_1093_annonc_mdy288_031 crossref_primary_10_1093_annonc_mdy288_031 elsevier_sciencedirect_doi_10_1093_annonc_mdy288_031 |
| PublicationCentury | 2000 |
| PublicationDate | October 2018 2018-10-00 2018-Oct |
| PublicationDateYYYYMMDD | 2018-10-01 |
| PublicationDate_xml | – month: 10 year: 2018 text: October 2018 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Annals of oncology |
| PublicationTitleAlternate | Ann Oncol |
| PublicationYear | 2018 |
| Publisher | Elsevier Ltd |
| Publisher_xml | – name: Elsevier Ltd |
| SSID | ssj0006929 |
| Score | 2.2659364 |
| SourceID | unpaywall pubmed crossref elsevier |
| SourceType | Open Access Repository Index Database Enrichment Source Publisher |
| StartPage | viii412 |
| Title | Phase I/II, open-label, multiple ascending dose trial of AGEN2034, an anti–PD-1 monoclonal antibody, in advanced solid malignancies: Results of dose escalation in advanced cancer and expansion cohorts in subjects with relapsed/refractory cervical cancer |
| URI | https://dx.doi.org/10.1093/annonc/mdy288.031 https://www.ncbi.nlm.nih.gov/pubmed/32137035 https://academic.oup.com/annonc/article-pdf/29/suppl_8/mdy288.031/26140708/mdy288.031.pdf |
| UnpaywallVersion | publishedVersion |
| Volume | 29 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1569-8041 dateEnd: 20241102 omitProxy: true ssIdentifier: ssj0006929 issn: 0923-7534 databaseCode: DIK dateStart: 19960101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1569-8041 dateEnd: 20241102 omitProxy: true ssIdentifier: ssj0006929 issn: 0923-7534 databaseCode: GX1 dateStart: 19960101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lj9MwELZ2uxKcljcsgpUPnKBOEzsPm1sF-yjSVhWiUvcU-RWoCG3VtFq6J_4D_5A_AuM4KQuHXXFAqlQpGs8kmXHmG3s8g9ALLTLh6oCRJC0KEqdhQWSkLRGGq9BkSvK6dufZMD0dx-8myWQHnbdnYWSTFR60RxrkDMJg3WveI1mYokcFaAkwWs4hat9QzgOwzB6EAhCchFevBUC9i_bSBGB6B-2Nh6P-eV17jzICML3ecU5SQVwNnnbHU7BW5G8-N_qs2-vZQm4uZFlecU7Hd9Bl-1g-J-VzsF6pQF_-VfHxvzz3XbTfQFrc9zzuoR07u49unTWb9g_Qz9EncJV40BsMuth16yJgebbs4jaZEUtXUso5UWzmQFl3EsHzAvdPjoY0ZHEXyxn8VtMf376P3pIIw9yZ69IFEfVlNTebLp4CTZPRgGFGTQ3-AkHGR99_uHqN39sKBFaOcS3GVmCftWH-MVS7vyXwNdh-hW-lW07Ero_wEsYCYbVWbu2qwm4JG7uzQIvKmh5obVn3LtpgXX9_4d48q4dofHz04c0pafpOEE0zHhGhIghTjUptnLkCilRFAGopOPnQFJZZ7mo785RnyhilLIUgmorCGq1TyYyN2SPUAeXZJwgroagGDEVDwQEqFVwyFSduISBiXIrkAIWtZeW6KcrueoOUuU8OYLm3g9wrNwflHqCX2yELX5HkOuK4Nde8gVQeKuXgMa8b9tib9lYCoxED5wA3_Gpr6zeLf_pP1M9QZ7Vc2-eA8lbqEO2eTKLDZtb-AlrvV_c |
| linkProvider | Unpaywall |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxELZKKsGpvGkRIB84QbwPex82twhaGqRGESJSe1r5tSViSaJsIkhP_Af-IX8ExuvdUDi04oAUKdJqPLO7M975xh7PIPRci1y4OmAkzcqSJFlUEhlrS4ThKjK5kryp3Xkyyo4nybvT9HQHnXVnYWSbFR50RxrkDMJgHbbvkSxMGVIBWgKMVnCI2jeU8wAsM4RQAIKT6PK1AKhvoN0sBZjeQ7uT0Xhw1tTeo4wATG92nNNMEFeDp9vxFKwT-ZvPtT7r1nq2kJsvsqouOaej2-iieyyfk_IpWK9UoC_-qvj4X577DtprIS0eeB530Y6d3UM3T9pN-_vo5_gjuEo8DIfDPnbdughYnq36uEtmxNKVlHJOFJs5UDadRPC8xIO3hyMasaSP5Qx-q-mPb9_Hb0iMYe7MdeWCiOaymptNH0-Bps1owDCjpgZ_hiDj3Pcfrl_h97YGgbVj3IixNdhnY5h_DNXubwl8DbZf4VvplhOx6yO8hLFAWK-VW7uqsVvCxu4s0KK2JgStLZveRRusm-8v3Jtn9QBNjg4_vD4mbd8JomnOYyJUDGGqUZlNcldAkaoYQC0FJx-Z0jLLXW1nnvFcGaOUpRBEU1Fao3UmmbEJe4h6oDy7j7ASimrAUDQSHKBSySVTSeoWAmLGpUgPUNRZVqHbouyuN0hV-OQAVng7KLxyC1DuAXqxHbLwFUmuIk46cy1aSOWhUgEe86phj7xpbyUwGjNwDnDDL7e2fr34x_9E_QT1Vsu1fQoob6WetfP1F1DPVwY |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Phase+I%2FII%2C+open-label%2C+multiple+ascending+dose+trial+of+AGEN2034%2C+an+anti%E2%80%93PD-1+monoclonal+antibody%2C+in+advanced+solid+malignancies%3A+Results+of+dose+escalation+in+advanced+cancer+and+expansion+cohorts+in+subjects+with+relapsed%2Frefractory+cervical+cancer&rft.jtitle=Annals+of+oncology&rft.au=Drescher%2C+C.&rft.au=Moore%2C+K.N.&rft.au=Liu%2C+J.F.&rft.au=O%E2%80%99Malley%2C+D.M.&rft.date=2018-10-01&rft.issn=0923-7534&rft.volume=29&rft.spage=viii412&rft.epage=viii413&rft_id=info:doi/10.1093%2Fannonc%2Fmdy288.031&rft.externalDBID=n%2Fa&rft.externalDocID=10_1093_annonc_mdy288_031 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0923-7534&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0923-7534&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0923-7534&client=summon |